Abstract
More than 20 diseases have been identified which are caused by the deposition of amyloid. Natural and chemically synthesized amyloidogenic proteins are used widely to study the structure, assembly,and physiologic effects of both oligomeric and fibrillar forms of these proteins. In many cases,conflicting results arise in these studies,in part owing to difficulties in reproducibly preparing amyloidogenic proteins in a well-defined assembly state.To avoid these problems, several methods have been devised that provide reliable means of preparing amyloid-forming proteins for experimental use.Here,we discuss methods that have been used successfully to prepare one such protein,the amyloid #x03B2; protein (Aβ,involved in Alzheimer's disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Simmons, L. K., May, P. C., Tomaselli, K. J., et al. (1994) Secondary structure of amyloid βpeptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373–379.
Howlett, D. R., Jennings, K. H., Lee, D. C., et al. (1995) Aggregation state and neu-rotoxicproperties of Alzheimer β-amyloid peptide. Neurodegeneration 4, 23–32.
Soto, C., Castaño, E. M., Kumar, R. A., Beavis, R. C., and Frangione, B. (1995) Fibrillogenesis of synthetic amyloidβ peptides is dependent on their initial sec-ondarystructure. Neurosci. Lett. 200, 105–108.
Rabanal, F., Tusell, J. M., Sastre, L., et al. (2002) Structural, kinetic and cytotox-icity aspects of 12–28 β amyloid protein fragment: A reappraisal. J. Pept. Sci. 8,578–588.
Bitan, G., Lomakin, A., and Teplow, D. B. (2001) Amyloid β-protein oligomer-ization:prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276, 35176–35184.
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis-Detection of a protofibrillar interme-diate. J. Biol. Chem. 272, 22364–22372.
Fezoui, Y., Hartley, D. M., Harper, J. D., et al. (2000) An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments. Amyloid: Int. J. Exp. Clin. Invest. 7, 166–178.
Jao, S. C., Ma, K., Talafous, J., Orlando, R., and Zagorski, M. G. (1997) Trifluoro-aceticacid pretreatment reproducibly disaggregates the amyloid β-peptide. Amyloid:Int. J. Exp. Clin. Invest. 4, 240–252.
Nilsson, M. R., Nguyen, L. L., and Raleigh, D. P. (2001) Synthesis and purifica-tion of amyloidogenic peptides. Anal. Biochem. 288, 76–82.
Harper, J. D. and Lansbury, P. T. Jr. (1997) Models of amyloid seeding in Alz-heimer'disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385–407.
Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., and Teplow, D. B. (2003) Amyloid βprotein (A β;) assembly: Aβ40 and Aβ 42 oligo-merizethrough distinct pathways. Proc. Natl. Acad. Sci. USA 100, 330–335.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Bitan, G., Teplow, D.B. (2005). Preparation of Aggregate-Free,Low Molecular Weight Amyloidβ for Assembly and Toxicity Assays. In: Sigurdsson, E.M. (eds) Amyloid Proteins. Methods in Molecular Biology™, vol 299. Humana Press. https://doi.org/10.1385/1-59259-874-9:003
Download citation
DOI: https://doi.org/10.1385/1-59259-874-9:003
Publisher Name: Humana Press
Print ISBN: 978-1-58829-337-4
Online ISBN: 978-1-59259-874-8
eBook Packages: Springer Protocols